A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron.

Clinical trial NCT01284868 · COMPLETED

Trial details

NCT number: NCT01284868
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Pharmacodynamics of Mirabegron

Start date: 2009-07-01
Primary completion: 2009-11-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.